The profile of tamoxifen user due to gynecomastia induced by anabolic steroids for bodybuilders or bodybuilding

• Main Authors: E. Santos, E. F. Souza, J. C. H. Antonio, K. C. Silva, S. A. Marques, V. C. G. Soares
• Format: Article
• Language: English
• Published: Universidade Federal de Rondonópolis 2016-09-01
• Series: Scientific Electronic Archives
• Subjects: gynecomastia, anabolics, tamoxifen, bodybuilding, estrogens, androgens, hypertrophy
• Online Access: https://sea.ufr.edu.br/index.php?journal=SEA&page=article&op=view&path=267

Due to valorization of body appearance, the seek for a good physic body gets a central importance in externalization of subjectivity and in the construction the identities of the people. Because of this, them invest time to look for devices to streamline results to get a perfect body, between mechanisms used there is the use of anabolic steroids (AS). With the rapid response this kind of treatment, there are aware concerns their side effects such as gynecomastia which is characterized by breast enlargement of man. In an attempt to prevent this effect aesthetically uncomfortable, the users seek take medicines such as tamoxifen to reverse or prevent this situation without proper prescription or monitoring of a pharmacist professional, as well as almost all treatments with EA which are made clandestinely. This work aimed to describe profile among consumers seeking the tamoxifen therapy to prevent or treat gynecomastia induced using EA. The target audience was composed of bodybuilders men that were making anabolic cycles, aiming fast muscular hypertrophy. Two questionnaires were applied, one to the drugstores that sell these drugs and one for bodybuilders who buy these drugs. Tamoxifen user profile found in this study shows that they are young people aged 18 to 35 years old, seeking muscle hypertrophy strength. As the natural results are slow, influenced by training friends, start using EA, even declaring know about the risks to health. Use along with these steroids, tamoxifen, in an attempt to prevent or treat gynecomastia, get the medication in drugstores without a prescription and without the pharmacist questioning, demonstrating that pharmaceutical care is still not fully deployed and functioning.